Newsroom

Press Releases

Welcome to the DermTech newsroom. Here you’ll find up-to-date information about the company, including our latest press releases, media coverage, events and our blog.

DermTech Announces Clinical Study to Assess DNA Damage and Reversal

DermTech, Inc., the global leader in non-invasive molecular dermatology, announced today it has initiated enrollment in a clinical study to assess DNA damage induced by an excimer laser and evaluate the potential of T4 endonuclease topical DNA repair enzyme and photolyase cream to reduce this DNA damage as measured through gene expression analysis.

read more

DermTech and Harvard Publish Two Clinical Studies at IID

DermTech, Inc., the global leader in non-invasive molecular dermatology, announced today the publication of two clinical study abstracts at the 2018 International Investigational Dermatology meeting in Orlando, Fl. A real world clinical utility study, “Real-world experience and clinical utility of a non-invasive gene expression test for primary cutaneous melanoma and validation against high risk driver mutations in BRAF, NRAS and the TERT promoter”….

read more

DermTech Announces Completion of Carcinome™ Clinical Study Enrollment

DermTech, Inc., the global leader in non-invasive molecular dermatology, announced completion of enrollment in the Carcinome™ clinical study. The goal of the Carcinome™ study is to develop a non-invasive genomic test to differentiate basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) from non-cancerous lesions like actinic keratosis. More than 600 patients were enrolled in this study.

read more

DermTech Announces Melanoma Research Foundation Walk Support

LA JOLLA, Calif., May 3, 2018 /PRNewswire/ — DermTech, Inc., the global leader in non-invasive molecular dermatology, announced it is partnering with the Melanoma Research Foundation in support of five Miles for Melanoma Run/Walks held throughout the US, kicking off this month during Melanoma Awareness Month.

read more

DermTech Receives State of New York Laboratory Permit

DermTech, Inc., the global leader in non-invasive molecular dermatology, announced it has received permitting from the State of New York, Department of Public Health. The addition of a New York permit to DermTech’s current accreditations, allows it to now provide laboratory services across the United States in all 50 states and the District of Columbia.

read more